Alfred J. Ford Jr.
Net Worth

Last updated:

What is Alfred J. Ford Jr. net worth?

The estimated net worth of Mr. Alfred J. Ford Jr. is at least $13,156,715 as of 31 Jan 2024. He has earned $10,309,915 from insider trading and has received compensation worth at least $2,846,800 in Axonics, Inc..

What is the salary of Alfred J. Ford Jr.?

Mr. Alfred J. Ford Jr. salary is $569,360 per year as Chief Commercial Officer in Axonics, Inc..

How old is Alfred J. Ford Jr.?

Mr. Alfred J. Ford Jr. is 54 years old, born in 1971.

What stocks does Alfred J. Ford Jr. currently own?

As insider, Mr. Alfred J. Ford Jr. owns shares in one company:

Company Title Shares Price per share Total value
Axonics, Inc. (AXNX) Chief Commercial Officer 43,450 $0 $0

What does Axonics, Inc. do?

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Alfred J. Ford Jr. insider trading

Axonics, Inc.

Mr. Alfred J. Ford Jr. has made 19 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 54,296 units of AXNX stock on 19 Apr 2021. As of 31 Jan 2024 he still owns at least 43,450 units of AXNX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Performance-Based Restricted Stock Units 15,000 N/A N/A
Sale
Common Stock 16,615 $67.74 $1,125,434
Option
Common Stock 25,500 N/A N/A
Sale
Common Stock 14,769 $62.34 $920,670
Sale
Common Stock 1,500 $62.01 $93,021
Sale
Common Stock 3,164 $61.02 $193,055
Sale
Common Stock 541 $60.44 $32,695
Option
Common Stock 16,500 N/A N/A
Sale
Common Stock 4,235 $61.17 $259,051
Option
Performance-Based Restricted Stock Units 11,250 N/A N/A
Sale
Common Stock 1,999 $61.12 $122,183
Option
Stock Option (Right to Buy) 9,310 $25.82 $240,384
Option
Stock Option (Right to Buy) 8,509 $1.42 $12,083
Sale
Common Stock 17,108 $66.69 $1,140,881
Sale
Common Stock 3,615 $67.18 $242,841
Option
Common Stock 8,509 $1.42 $12,083
Sale
Common Stock 15,292 $65.9 $1,007,697
Option
Common Stock 1,899 $1.63 $3,095
Option
Common Stock 16,297 $14.19 $231,254
Option
Common Stock 9,310 $25.82 $240,384
Option
Common Stock 24,130 N/A N/A
Option
Performance-Based Restricted Stock Units 14,130 N/A N/A
Sale
Common Stock 470 $49.04 $23,046
Sale
Common Stock 8,797 $48.21 $424,103
Option
Common Stock 46,197 $10.77 $497,311
Option
Common Stock 46,197 N/A N/A
Option
Stock Option (Right to Buy) 46,197 N/A N/A
Option
Common Stock 46,197 N/A N/A
Sale
Common Stock 54,296 N/A N/A
Sale
Common Stock 54,296 $58.83 $3,194,016
Option
Common Stock 5,334 N/A N/A
Sale
Common Stock 1,883 N/A N/A
Sale
Common Stock 1,883 N/A N/A
Option
Performance-Based Restricted Stock Units 2,667 N/A N/A
Option
Performance-Based Restricted Stock Units 7,065 N/A N/A
Sale
Common Stock 2,417 N/A N/A
Option
Common Stock 7,065 N/A N/A
Option
Common Stock 35,000 $1.42 $49,700
Sale
Common Stock 35,000 $40.53 $1,418,375
Option
Stock Option (Right to Buy) 35,000 $1.42 $49,700
Sale
Common Stock 2,667 $42.31 $112,846
Option
Common Stock 2,667 N/A N/A
Option
Performance-Based Restricted Stock Units 2,667 N/A N/A

Axonics key executives

Axonics, Inc. executives and other stock owners filed with the SEC: